D
Dana S. Wollins
Researcher at American Society of Clinical Oncology
Publications - 38
Citations - 5276
Dana S. Wollins is an academic researcher from American Society of Clinical Oncology. The author has contributed to research in topics: Cancer & Health care. The author has an hindex of 21, co-authored 38 publications receiving 4530 citations. Previous affiliations of Dana S. Wollins include City of Hope National Medical Center & University of Pittsburgh.
Papers
More filters
Journal ArticleDOI
American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility
Mark E. Robson,Mark E. Robson,Angela R. Bradbury,Banu Arun,Susan M. Domchek,James M. Ford,Heather Hampel,Stephen M. Lipkin,Sapna Syngal,Dana S. Wollins,Noralane M. Lindor +10 more
TL;DR: This statement makes recommendations in the following areas: germline implications of somatic mutation profiling, multigene panel testing for cancer susceptibility, quality assurance in genetic testing, education of oncology professionals, and access to cancer genetic services.
Journal ArticleDOI
American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options
Lowell E. Schnipper,Nancy E. Davidson,Dana S. Wollins,Courtney Tyne,Douglas W. Blayney,Diane Blum,Adam P. Dicker,Patricia A. Ganz,J. Russell Hoverman,Robert M. Langdon,Gary H. Lyman,Neal J. Meropol,Therese M. Mulvey,Lee N. Newcomer,Jeffrey Peppercorn,Blase N. Polite,Derek Raghavan,Gregory Rossi,Leonard B. Saltz,Deborah Schrag,Thomas J. Smith,Peter Paul Yu,Clifford A. Hudis,Richard L. Schilsky +23 more
TL;DR: The high costs associated with cancer care have created a difficult situation for patients and the oncologists who care for them and will require greater understanding of all the risks and benefits of various treatment options as well as the consequences of specific choices.
Journal ArticleDOI
American Society of Clinical Oncology Identifies Five Key Opportunities to Improve Care and Reduce Costs: The Top Five List for Oncology
Lowell E. Schnipper,Thomas J. Smith,Derek Raghavan,Douglas W. Blayney,Patricia A. Ganz,Therese M. Mulvey,Dana S. Wollins +6 more
TL;DR: This research highlights the need to understand more fully the role of Epstein-Barr virus in the development and Kessler-LaSalle syndrome, as well as its role in disease progression.
Journal ArticleDOI
Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received
Lowell E. Schnipper,Nancy E. Davidson,Dana S. Wollins,Douglas W. Blayney,Adam P. Dicker,Patricia A. Ganz,J. Russell Hoverman,Robert M. Langdon,Gary H. Lyman,Neal J. Meropol,Therese M. Mulvey,Lee N. Newcomer,Jeffrey Peppercorn,Blase N. Polite,Derek Raghavan,Gregory Rossi,Leonard B. Saltz,Deborah Schrag,Thomas J. Smith,Peter Paul Yu,Clifford A. Hudis,Julie M. Vose,Richard L. Schilsky +22 more
TL;DR: The value framework has been constructed as a conceptual model that incorporates the elements of clinical benefit, toxicity, and symptom palliation as derived from a comparative clinical trial and combines these elements into a score termed the net health benefit (NHB).
Journal ArticleDOI
American Society of Clinical Oncology Statement: Toward Individualized Care for Patients With Advanced Cancer
Jeffrey Peppercorn,Thomas J. Smith,Paul R. Helft,David Joseph Debono,Scott R. Berry,Dana S. Wollins,Daniel M. Hayes,Jamie H. Von Roenn,Lowell E. Schnipper +8 more
TL;DR: The goals for individualized care, barriers that currently limit realization of this vision, and possible strategies to overcome these barriers that can improve care consistent with the goals of patients and evidence-based medical practice are outlined.